Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Journal Volume
56
Journal Issue
6
Pages
1158–1168
Date Issued
2023-09-27
Author(s)
Abstract
Primary Aldosteronism (PA) is a common subtype of hypertension that increases the risk of adverse cardiovascular and kidney events. The impact of COVID-19 on patients with PA is not well understood. This study aimed to investigate the impact of COVID-19 on patients with PA and compare their outcomes with hypertensive patients with essential hypertension.
Subjects
COVID-19; Critical care; MACE; MAKE; Mortality; Primary aldosteronism; TAIPAI
SDGs
Type
journal article